BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22475224)

  • 1. Welcome to the '100% club'!
    Cohen J; Grudzinskas G; Johnson M
    Reprod Biomed Online; 2012 Apr; 24(4):375-6. PubMed ID: 22475224
    [No Abstract]   [Full Text] [Related]  

  • 2. Oocyte vitrification for elective fertility preservation: lessons for patient counseling.
    Stoop D
    Fertil Steril; 2016 Mar; 105(3):603-604. PubMed ID: 26773193
    [No Abstract]   [Full Text] [Related]  

  • 3. Accumulation of oocytes: a new strategy for managing low-responder patients.
    Cobo A; Garrido N; Crespo J; José R; Pellicer A
    Reprod Biomed Online; 2012 Apr; 24(4):424-32. PubMed ID: 22386762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oocyte vitrification as an efficient option for elective fertility preservation.
    Cobo A; García-Velasco JA; Coello A; Domingo J; Pellicer A; Remohí J
    Fertil Steril; 2016 Mar; 105(3):755-764.e8. PubMed ID: 26688429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro maturation of human immature oocytes for fertility preservation.
    Chian RC; Uzelac PS; Nargund G
    Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency.
    Suzuki N; Yoshioka N; Takae S; Sugishita Y; Tamura M; Hashimoto S; Morimoto Y; Kawamura K
    Hum Reprod; 2015 Mar; 30(3):608-15. PubMed ID: 25567618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Practical clinical aspects of oocyte vitrification for fertility preservation].
    Courbiere B; Decanter C
    Gynecol Obstet Fertil; 2014 Sep; 42(9):653-6. PubMed ID: 25164159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro oocyte maturation for female fertility preservation].
    Sonigo C; Grynberg M
    Gynecol Obstet Fertil; 2014 Sep; 42(9):657-60. PubMed ID: 25153445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indications for fertility preservation in women from malignant diseases to benign conditions to age-related fertility decline.
    Dolmans MM; Donnez J
    Minerva Ginecol; 2018 Aug; 70(4):402-407. PubMed ID: 29644332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility Preservation in 2016: Where Are We?
    David A; Green LJ; Shikanov A
    Semin Reprod Med; 2017 Mar; 35(2):160-166. PubMed ID: 28278533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications.
    Garcia-Velasco JA; Domingo J; Cobo A; Martínez M; Carmona L; Pellicer A
    Fertil Steril; 2013 Jun; 99(7):1994-9. PubMed ID: 23465707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertility preservation for age-related fertility decline.
    Stoop D; Cobo A; Silber S
    Lancet; 2014 Oct; 384(9950):1311-9. PubMed ID: 25283572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fertility preservation in cancer survivors.
    Winkler-Crepaz K; Ayuandari S; Ziehr SC; Hofer S; Wildt L
    Minerva Endocrinol; 2015 Jun; 40(2):105-18. PubMed ID: 25614989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.
    Doyle JO; Richter KS; Lim J; Stillman RJ; Graham JR; Tucker MJ
    Fertil Steril; 2016 Feb; 105(2):459-66.e2. PubMed ID: 26604065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is vitrification of oocytes useful for fertility preservation for age-related fertility decline and in cancer patients?
    Cobo A; Garcia-Velasco JA; Domingo J; Remohí J; Pellicer A
    Fertil Steril; 2013 May; 99(6):1485-95. PubMed ID: 23541405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitrification of in vitro matured oocytes collected from surplus ovarian medulla tissue resulting from fertility preservation of ovarian cortex tissue.
    Yin H; Jiang H; Kristensen SG; Andersen CY
    J Assist Reprod Genet; 2016 Jun; 33(6):741-6. PubMed ID: 26984232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live birth using vitrified--warmed oocytes in invasive ovarian cancer: case report and literature review.
    Alvarez M; Solé M; Devesa M; Fábregas R; Boada M; Tur R; Coroleu B; Veiga A; Barri PN
    Reprod Biomed Online; 2014 Jun; 28(6):663-8. PubMed ID: 24745835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction: Female fertility preservation: innovations and questions.
    Frydman R; Grynberg M
    Fertil Steril; 2016 Jan; 105(1):4-5. PubMed ID: 26612064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment.
    Domingo J; Guillén V; Ayllón Y; Martínez M; Muñoz E; Pellicer A; Garcia-Velasco JA
    Fertil Steril; 2012 Apr; 97(4):930-4. PubMed ID: 22283969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancer.
    Martinez M; Rabadan S; Domingo J; Cobo A; Pellicer A; Garcia-Velasco JA
    Reprod Biomed Online; 2014 Dec; 29(6):722-8. PubMed ID: 25444506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.